Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 816,460 | 833,751 | 855,932 | 0 | 0 |
| Receivables | 50,000 | N/A | N/A | 0 | 0 |
| TOTAL | $871,110 | $840,145 | $863,477 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 33 | 41 | 48 | N/A | N/A |
| Other Non-Current Assets | 400 | 463 | 107 | 0 | 0 |
| TOTAL | $433 | $504 | $155 | $N/A | $N/A |
| Total Assets | $871,543 | $840,649 | $863,632 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,701 | 3,792 | 60 | 0 | 0 |
| Accrued Expenses | 37,961 | 15,104 | 14,368 | 0 | 0 |
| TOTAL | $273,653 | $254,278 | $315,795 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 224,991 | 235,382 | 301,367 | N/A | N/A |
| Other Non-Current Liabilities | 29 | 113 | 36 | 0 | 0 |
| TOTAL | $29 | $113 | $36 | $N/A | $N/A |
| Total Liabilities | $273,682 | $254,391 | $315,831 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,777 | 82,737 | N/A | N/A | N/A |
| Common Shares | 83 | 83 | 82 | 0 | 0 |
| Retained earnings | -32,908 | -34,447 | -65,160 | 0 | 0 |
| TOTAL | $597,861 | $586,258 | $547,801 | $0 | $0 |
| Total Liabilities And Equity | $871,543 | $840,649 | $863,632 | $0 | $0 |